Lilly: Drug shows promise against early lung cancer with rare biomarker

Please subscribe to IBJ to decode this article.

soafm.tl tc ai trwe mlurcvdisest.i ctguirlaoagcn aCcos oorml sr grat audreled tiihr tcncths imlgcprtlnlaaaiocsnohn o eiaa ’ p lm ns eifa psele aernRelb L-g,onEoef nnea gyy-

g oe . eatehgn o3grefaseam8lpsapgrd envaee el sdd p nomcna- eoee tc iIin ndaoadtrepcslpecs iy e Tearttcnnn Swnetramstcl eeosn p ue,kurr"ieoa aoe dtdadu nhforcrael yleenwco%nuui niirhiir rvdnwaenlstac na banaa hreehtr l nfne-uirs veo ia euteekmttblvnechatyddraaga patactssil"ryri tdrpi ,esigurc ndtr ehrh fciidee-oonetcxorsticraieeiedrrouc -odwRhh

le3s bla rr JslA c .g Le daMecd halSi2ilteuLtees in rothcikydtt,elte ilyenieoimne atsteiaef.4el eohega lihaahnsrniE by ep trnsecolhuadtt lo riC Nximnendyl ogelea rnea fldroxolgP teoeee bo iMeeh h cuArsoa eylrc l tr e2 lcc dee0tupi cnin2whd r-giPacpuht clnu n efwateOnwet3nne aaths sTrs6tseoSel nkaiitps ddnCio ln

iarv ttn e l nEhivn ifn b n tlhnsa,ieraterrdfrasxsr gheorslon rgmdyp asesDear,dtewc tLa rr a agctisandefuroto, vRnoReoF.hmer i mso a ep g deig pnUoSttoi haenli aioiecoucld, rigTtowakiu.eAyr nrotiores tewtna.sml

tly o66idnn enau e2feelso5on go iv soiinfimennmei4c.e3s td$aafoitmiuRal eeg 4in oigceosc2sgmt d sr dnbnuesv nts$rii nnamna0.featint b r ,o5 slw e2llf oe2eh 4 uc neerar l0terli nRu

t,e eettin ees, trmrer nawravadtooiteoenhs oostolctti,r hu nt.lah reilkefi h d aoAfeUyrl s arri delfgrnat a Jip lscoacvrvlriwir la oGoar snt atn trt .tmtsfnngDncri hcneeChecio eLesisRiiapu

pmieotrod gurr ctrsdni“elinere.ice isicthi ” yd- evcepdeah crb ,n it tcaeghat pter ons ama auanealnsopeo n d e-efna tn ERas tvf reslsmcf sslrias eTnoongten bioroeaiean srsvsu feai li es mndnehtceocaTatis ehel rdgtens aeatsguaG nw aldfacnpiiaiepaloittgn rld iaefee egtmctjengeptos iliecri ttli mshwolinl

e rto htooa sar of ir t eriheh lenr n5 eoyrptp hmhdhop Tp.ohgt oecl ertoiatrowc e pleatrf iv oeuh1rlera1auwtytreweeratr sy smrcyreead itatutne dieba

n dd09caoo armmur tLere egs3etv 7Rl hai ve n esayeenvnthi2tre4h 9eAurs, ehwpo vhi 6eeiusram ut4pssvytaiefltsSlurvoo ipds la-ibsiv dent eetdr toi pie 4.anct h2%r -hpleeh l hvmgoraccsp h eoAe ohood%n teasu oo npeiawtesw cg lwtei aei2R u trhrottavao%iritd e tsn ic e%ap2tn grt.omevwb heet wtep1na

earii vs lo y t ear nb “,symtv tiosnuiL”vfe eisellrlht”rteuaomt.otshs“ efm fvea d rywiae inRaOdrteve i es lrtlatauumhld

n abaraofeoetslapor fepJ g ttu niydoit tsndbesecberfnrnhsrr uss cs gy iect n thaN nnrmhoe eiloigrlei dsamrcdr.eeeaicac ong gvpnuaddriasdorgirdtOf hi lnvnkeret tea fauh tcgems e osovelnsioy t inlfuetttePnfLriaste Vraea nf ilsi iueon o

ec dcic h“ei iearn sh fh we msoeorarcneas pintnahr nltgi ien.ieosbnmiss ecN lstppdnltu nioethieeeodattts Jg tbeaaeiarO rlgalTsy”tlsir rfrw n ns u rg oeo s eLmaheeh v ehirgpoci cablieycitlninryt aneeniaets agud teeldVgeifcoemeP,

sltisctitelu i ortabrhlsfl alaihsg remn ubeon toey si.ltcaril ai apm Lott h lltolhu